Cibus is a plant-based synthetic biology company that utilizes its proprietary PlantSpring technology platform to engineer plant metabolism to produce materials and products. Co. is focused on developing synthetic biology solutions through its PlantSpring technology platform for manufacture using its proprietary and differentiated BioFactory production system across a range of end markets, including the cosmeceutical, nutraceutical, and pharmaceutical industries. Co. also out-licenses elements of the PlantSpring technology platform and may selectively develop products in agriculture. Co.'s product, an improved digestibility alfalfa, was developed with and licensed to S&W Seed Company. The CBUS stock yearly return is shown above.
The yearly return on the CBUS stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2019 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the CBUS annual return calculation with any dividends reinvested as applicable (on ex-dates).
|